Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at a set CHADSVASC score. https://t.co/n2JKHLifnx Read paper. Save it. CHADSVASC calculator = folly https://t.co/WWpxS39KXk
Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2019 – Nov 2025Where it's discussed
-
X / Twitter32 posts
-
Facebook5 posts
-
News3 articles
-
YouTube2 videos
-
Blogs2 articles
AI synopsis
What people are saying
Overall, the discussions reflect a strong consensus that the study exposes significant flaws in current stroke risk prediction methods, with phrases like 'crushes the notion' and calls to 'rethink' risk assessments. The tone is urgent and critical, emphasizing the need for personalized approaches and highlighting the broad implications for clinical practice, which underscores the high impact and deep engagement from the community.
Most discussions highlight strong support for the paper’s findings, emphasizing that current risk assessment tools like CHADSVASC are unreliable, which reflects a consensus on the importance of reevaluating stroke risk estimation.
The posts demonstrate high curiosity and concern about stroke risk variability, with repeated references to the paper's revelations about the limitations of existing scoring systems, indicating deep interest.
Discussions include detailed references, such as mentions of specific studies, critiques of risk assessment methods, and calls to consider personalized approaches, showing active and in-depth engagement.
Many posts describe the paper as potentially transformative, arguing that it challenges established practices and could lead to changes in how clinical decisions are made for patients with atrial fibrillation, indicating a high level of perceived influenc
Abstract in brief
- The study found that the reported annual stroke rates in patients with atrial fibrillation (AF) vary widely across different studies, with rates ranging from 0.45 to 9.28 per year, and these differences are not fully explained by factors like region or study design.
- There is a significant discrepancy between the predicted stroke risks based on the CHADS2-VASc scoring system and the actual stroke rates observed in different populations, especially at lower risk scores. For example, many cohorts with a CHADS2-VASc score of 1 or 2 still reported low stroke rates, suggesting that the risk scores may not uniformly apply across different patient groups.
- Overall, the findings indicate that stroke risk in AF patients is highly variable, which could impact how we use these risk scores to guide anticoagulant therapy and underscores the need for more personalized risk assessment approaches.
Top posts
Most liked on X and BlueskyThis paper crushes the notion of using CHADSVASC score. https://t.co/cBpug3K7rE We hardly know the untreated risk! https://t.co/pfysDYJARg
@venkmurthy @sonodoc99 @VPrasadMDMPH @AndrewFoy82 This is a super important paper. Quinn et al. https://t.co/n2JKHLifnx It shows huge variation of stroke risk in untreated AF pts across CHADSVASC categories. The notion that a CHADVASC of X corresponds to Y stroke risk is utter fantasy.
@DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out these 2 important papers This from @hoomankamel et al https://t.co/cAmpSAUMjg This from Quinn et al https://t.co/n2JKHLifnx What we DO NOT know in the AF-stroke space is incredible. Future generations will laugh at our worship of the CHADSVASC
@bogdienache @SZDiederichsen @EJSMD One of the most under cited papers. IMO — shows we really don’t know un-treated stroke risk. (Link) That + such early termination makes we wonder about a potential pro-coagulant effect from XI cc @kaulcsmc https://t.co/kwnVfJCRkz
@adnanalkhouli @drpaulfriedman @DrTomEP @DJ_Lakkireddy @djc795 @ba_steinberg @davidrholmes2 @cardiacpolymath @SurajKapa @abhishek_mbbs @melchami99 @guroledip Agree with @djc795 re high competing risk of mortality and variable stroke rates among different cohorts. https://t.co/tITcoVUwQN
All mentions
Variability in Stroke Rates Among Atrial Fibrillation Patients
This week in cardiology, John Mandrola MD discusses findings that stroke rates in AF patients vary widely across studies, highlighting discrepancies between predicted and observed risks and emphasizing the need for…
Advances in Heart Failure Treatment and Atrial Fibrillation Management
This week in cardiology, John Mandrola MD discusses recent trials, including PARACHUTE HF, DAPA ACT, HFTIMI 68, and AMALFI, focusing on innovative treatments for heart failure and atrial fibrillation. The content…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
RT @drjohnm: Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at…
Please look at Gene Quinn et al paper. The problem and this is warning. You can’t unsee the massive variance in stroke risk at a set CHADSVASC score. https://t.co/n2JKHLifnx Read paper. Save it. CHADSVASC calculator = folly https://t.co/WWpxS39KXk
https://t.co/xJATxxuzpz Conclusions: majority of cohorts did not observe #stroke rates that would indicate a clear expected net #clinical benefit for #anticoagulating #AF patients with CHA2DS2-VASc scores of 1 or 2. @ACCinTouch @AmerMedicalAssn @American_Heart @CardiologyToday
@bogdienache @SZDiederichsen @EJSMD One of the most under cited papers. IMO — shows we really don’t know un-treated stroke risk. (Link) That + such early termination makes we wonder about a potential pro-coagulant effect from XI cc @kaulcsmc https://t.co/kwnVfJCRkz
RT @drjohnm: @DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out…
RT @drjohnm: @DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out…
RT @drjohnm: This paper crushes the notion of using CHADSVASC score. https://t.co/cBpug3K7rE We hardly know the untreated risk! https://…
RT @drjohnm: This paper crushes the notion of using CHADSVASC score. https://t.co/cBpug3K7rE We hardly know the untreated risk! https://…
RT @drjohnm: This paper crushes the notion of using CHADSVASC score. https://t.co/cBpug3K7rE We hardly know the untreated risk!
This paper crushes the notion of using CHADSVASC score. https://t.co/cBpug3K7rE We hardly know the untreated risk! https://t.co/pfysDYJARg
@DrJasonAndrade 1) Would you have expected lower? 2) I wanna push back on your projected stroke rate. I think we kid ourselves thinking we know the annual untreated stroke rate. See one of my faves: Quinn et al https://t.co/6G3U9HG1Gv
RT @DocStrom: @adnanalkhouli @drpaulfriedman @DrTomEP @DJ_Lakkireddy @djc795 @ba_steinberg @davidrholmes2 @cardiacpolymath @SurajKapa @abhi…
RT @DocStrom: @adnanalkhouli @drpaulfriedman @DrTomEP @DJ_Lakkireddy @djc795 @ba_steinberg @davidrholmes2 @cardiacpolymath @SurajKapa @abhi…
@adnanalkhouli @drpaulfriedman @DrTomEP @DJ_Lakkireddy @djc795 @ba_steinberg @davidrholmes2 @cardiacpolymath @SurajKapa @abhishek_mbbs @melchami99 @guroledip Agree with @djc795 re high competing risk of mortality and variable stroke rates among different cohorts. https://t.co/tITcoVUwQN
RT @drjohnm: @DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out…
RT @drjohnm: @DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out…
RT @drjohnm: @DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out…
@DrLindaDykes @venkmurthy @pash22 @mancunianmedic @DrAoifeMolloy @MarshallProf @drtimwilson @AndrewFoy82 @AFPJournal Check out these 2 important papers This from @hoomankamel et al https://t.co/cAmpSAUMjg This from Quinn et al https://t.co/n2JKHLifnx What we DO NOT know in the AF-stroke space is incredible. Future generations will laugh at our worship of the CHADSVASC
RT @drjohnm: @venkmurthy @sonodoc99 @VPrasadMDMPH @AndrewFoy82 This is a super important paper. Quinn et al. https://t.co/n2JKHLifnx It sh…
RT @drjohnm: @venkmurthy @sonodoc99 @VPrasadMDMPH @AndrewFoy82 This is a super important paper. Quinn et al. https://t.co/n2JKHLifnx It sh…
RT @drjohnm: @venkmurthy @sonodoc99 @VPrasadMDMPH @AndrewFoy82 This is a super important paper. Quinn et al. https://t.co/n2JKHLifnx It sh…
RT @drjohnm: @venkmurthy @sonodoc99 @VPrasadMDMPH @AndrewFoy82 This is a super important paper. Quinn et al. https://t.co/n2JKHLifnx It sh…
@venkmurthy @sonodoc99 @VPrasadMDMPH @AndrewFoy82 This is a super important paper. Quinn et al. https://t.co/n2JKHLifnx It shows huge variation of stroke risk in untreated AF pts across CHADSVASC categories. The notion that a CHADVASC of X corresponds to Y stroke risk is utter fantasy.
JM
JF
JS
JG
ME
RM
HT
RS
CR
NA
SM
AM
JF
AP
S
DF
DB
AF
N
MM
EM
DB
CA
RM
SM
VP